Alps Group Inc. Receives MS ISO 15189:2022 Accreditation for Whole Genome Sequencing

Alps Group Inc. has expanded its MyGenome accreditation to include whole genome sequencing under the MS ISO 15189:2022 standard. This update confirms that the company’s laboratory processes for comprehensive genetic analysis now meet the international quality and competence requirements established by the Department of Standards Malaysia.

The MS ISO 15189:2022 certification serves as a formal recognition of a medical laboratory’s technical proficiency and management systems. By incorporating whole genome sequencing into this accredited scope, Alps Group Inc. aligns its diagnostic operations with updated global benchmarks for clinical laboratory testing. This accreditation process involves rigorous assessments of laboratory staff competency, equipment calibration, and the accuracy of analytical procedures used to interpret genetic data. The company now maintains this standardized framework for its full suite of genomic services, ensuring that its testing protocols adhere to the specific quality management criteria mandated by the accreditation body.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 9, 2026

Author

GOAI